With Cell-By-Cell Take on Drug Discovery, Immunitas Debuts With $39M

Submitted by admin on November 21, 2019 - 11:34pm

Source:

Xconomy

News Tags:

Immunitas Therapeutics

single-cell genomics

cancer

drug discovery

Headline:

With Cell-By-Cell Take on Drug Discovery, Immunitas Debuts With $39M

snippet:

A cancer tumor is a veritable patchwork of cells with a variety of genetic fingerprints.

Immunitas Therapeutics is using single-cell genomics—an approach that studies the genetic activity of individual cells—to peer deeply into patient tumors and more precisely determine what is fueling the growth.

Search form

You are here

With Cell-By-Cell Take on Drug Discovery, Immunitas Debuts With $39M

With Cell-By-Cell Take on Drug Discovery, Immunitas Debuts With $39M